APC Anti-Human CD273/PD-L2 Antibody[24F.10C12]

APC Anti-Human CD273/PD-L2 Antibody[24F.10C12]

The APC Anti-Human CD273/PD-L2 Antibody[24F.10C12] is a highly specific and reliable tool designed for the detection and analysis of CD273, also known as Programmed Death Ligand 2 (PD-L2), in human samples. This antibody is conjugated with Allophycocyanin (APC), a bright and photostable fluorochrome, enabling easy and efficient flow cytometric analysis. With its exceptional specificity, this antibody ensures accurate identification and quantification of CD273/PD-L2 expression on various cell types, aiding in the understanding of immune responses and the development of immunotherapeutic strategies.

The APC Anti-Human CD273/PD-L2 Antibody[24F.10C12] exhibits outstanding performance in terms of sensitivity and signal-to-noise ratio. It has been extensively validated for flow cytometry applications, providing consistent and reproducible results. This antibody recognizes the extracellular domain of CD273/PD-L2, a key immune checkpoint molecule that plays a crucial role in regulating T cell responses. By targeting CD273/PD-L2, researchers can gain valuable insights into the immune system's ability to modulate immune responses and its potential implications in diseases such as cancer, autoimmune disorders, and infectious diseases.

This antibody is manufactured using state-of-the-art techniques, ensuring high purity and batch-to-batch consistency. It is supplied in a ready-to-use format, eliminating the need for time-consuming sample preparation. The APC Anti-Human CD273/PD-L2 Antibody[24F.10C12] is suitable for use in both research and clinical settings, enabling scientists and clinicians to investigate the expression and function of CD273/PD-L2 in various biological samples. With its exceptional performance and reliability, this antibody is an indispensable tool for advancing our understanding of immune regulation and developing novel therapeutic interventions.